Status of Immunotherapy Acceptance in Chinese Patients With Multiple Sclerosis: Analysis of Multiple Sclerosis Patient Survival Report 2018Ran Zhou, Weihong Zheng, Bitao Bu et al.|Frontiers in Neurology|2021Cited by 13
Granzyme B in circulating CD8+ T cells as a biomarker of immunotherapy effectiveness and disability in neuromyelitis optica spectrum disordersZiyan Shi, Hongyu Zhou, Qin Du et al.|Frontiers in Immunology|2022Cited by 13
P1163 ALL-ORAL THERAPY WITH DACLATASVIR IN COMBINATION WITH ASUNAPREVIR AND BMS-791325 FOR TREATMENT-NAIVE PATIENTS WITH CHRONIC HCV GENOTYPE 4 INFECTIONTarek Hassanein, David Gardiner, Karen Sims et al.|Journal of Hepatology|2014Cited by 12
Brain changes correlate with neuropathic pain in patients with neuromyelitis optica spectrum disordersHongxi Chen, Hongyu Zhou, Zhiyun Lian et al.|Multiple Sclerosis and Related Disorders|2021Cited by 10
Seasonal variation in relapse of neuromyelitis optica spectrum disorders: A retrospective study in ChinaYuhan Qiu, Hongyu Zhou, Qiao Zhou et al.|Journal of Neuroimmunology|2020Cited by 6